Lab-on-Card TechnologyProof-of-concept

Imagine a world where clinical diagnostics is done with nothing but a simple card. GeneSpector offers a groundbreaking solution using passive chips with nanofluidic structures for complex sample work-up, analyte detection, and result visualization. This method, executable anywhere—even in field conditions—provides robust, fast results with a simple readout at a low price. Applicable for diagnosing conditions like myocardial infarction and infectious diseases, it requires only a drop of a biological sample (e.g., blood, saliva, urine). To develop the technology, GeneSpector in collaboration with IQS Group decided to found a spin-off company in 2024 called Lab On Card (www.laboncard.com).

Pipeline

Product / technology
(target/biomarker)
Discovery stageDevelopmentScale-upCommercializationCommercial partner
Proof-of-conceptPre-clinic dataClinical validationCE / IVDRMarket
Lab-on-Card
Technology
Progress: 14 %IQS Group

Project details

Imagine a world where clinical diagnostics is done with nothing but a credit card.

Accessibility of clinical diagnostics can be problematic and limited in both developing and developed countries. Reasons being high price point, lack of suitable infrastructure, necessity of sophisticated instrumentation, or limited capacities of diagnostic laboratories.

GeneSpector Innovations presents a solution providing a diagnostic method based on passive chips equipped with nanofluidic structures for complex sample work-up, analyte detection, and result visualization. Such methods can be performed anywhere—even in field conditions—with simple execution and without complicated instrumentation. Analysis can be robust with fast results and simple readout for a low price.

Possibilities are endless. From diagnosis of myocardial infarction via specific markers to diagnosis of infectious diseases. All that is needed is to apply a drop of a biological sample (e.g., blood, saliva, urine) and wait.

Contact

GeneSpector s.r.o.
Petrska 1180/3 110 00 Prague, Czech Republic
ID No / IČO: 09404546, file number C 335854
administered by the Municipal Court in Prague

General queries,
investors & partners

info@genespector.com

 

US subsidiary

GeneSpector Innovations USA, Inc.
3500 South Dupont Highway
Dover DE 19901

EU subsidiary

GeneSpector s.r.o.
Petrska 1180/3
110 00 Prague, Czech Republic
ID No / IČO: 09404546
File number C 335854
administered by
the Municipal Court in Prague